The Impact of New Emerging Drugs in the Treatment of Multiple Myeloma:Is there Still a Role for PBSC Transplantation?

E-ISSN： 2212-3946|2|1|1-11

ISSN： 1574-888X

Source： Current Stem Cell Research & Therapy, Vol.2, Iss.1, 2007-01, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of carfilzomib in the treatment of multiple myeloma

By Khan Rashid Z Badros Ashraf

Expert Review of Hematology, Vol. 5, Iss. 4, 2012-08 ,pp. : 361-372

Informa Healthcare

Access to resources Recommend Favorite

Towards a new age in the treatment of multiple myeloma

By Piazza Francesco Gurrieri Carmela Trentin Livio Semenzato Gianpietro

Annals of Hematology, Vol. 86, Iss. 3, 2007-03 ,pp. : 159-172

Springer Publishing Company

Access to resources Recommend Favorite

Immunomodulatory drugs in multiple myeloma

By Andhavarapu Swati Roy Vivek

Expert Review of Hematology, Vol. 6, Iss. 1, 2013-02 ,pp. : 69-82

Informa Healthcare

Access to resources Recommend Favorite

Stem cell transplantation in multiple myeloma

By Björkstrand Bo

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 26-28

Maney Publishing

Access to resources Recommend Favorite

Role of stem cell transplantation in myeloma

By Gahrton G. Iacobelli S. Björkstrand B. Bourhis J. Corradini P. Crawley C. Morris C. Niederwieser for the European Group for Blood and Marrow Transplantation(EBMT) D.

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 127-128

Maney Publishing

Access to resources Recommend Favorite